Up to 18 hours of Physician and Pharmacist credits may be available.
Registration and more information at ichs.org.
Up to 18 hours of Physician and Pharmacist credits may be available.
Registration and more information at ichs.org.
Final Day for the ICHS Educational Webcast. The ICHS online resource will be end on Friday, February 27, 2026. Visit ICHS.org for more information on this session, and all available on demand education.
ICHS Educational Webcast Available for a Limited Time! The ICHS online resource will be end on Friday, February 27, 2026. Visit ICHS.org for more information on this session, and all available on demand education.
Hear from our President as he invites you to engage and network with global leading experts while exploring groundbreaking emerging therapies in the care of immunocompromised patients.
Register at www.ichs.org
@kottonnelson.bsky.social
President's Invitation - join us for the opportunity to engage and network with global leading experts to discuss groundbreaking emerging therapies in the care of immunocompromised patients. buff.ly/JIJNZgo. Register @ichs.org. @ChemalyRoy @CamilleKotton
Celebrate excellence and join us in Houston. Register to see Dr. Kontoyiannis receive this award, and for his insightful presentation. ichs.org. @chemalyroy @CamilleKotton
Join over 900 members across 58 countries and gain access to a wealth of resources, networking opportunities, and exclusive benefits tailored to support your professional growth. Enhance patient care by actively engaging with a community of experts. ICHS.org
ICHS is honored to list our Council Member Dr. Murat Akova as the recipient of the
2026 ESCMID Lifetime Achievement Award! Visit ICHS.org for the complete announcement, and more ESCMID news. Congratulations Dr. Akova!
Please take advantage of these online, dynamic sessions for pivotal moments in education, advancing research, diagnostics, and therapeutics for immunocompromised populations. Visit ichs.org for a list of on-demand sessions.
One week for this educational webinar opportunity on Wednesday, January 21st at 12:00 pm CT.
More information and registration at ichs.wildapricot.org/page-1863412
#chemalyroy
Please take advantage of these online, dynamic sessions for pivotal moments in education, advancing research, diagnostics, and therapeutics for immunocompromised populations. Visit ichs.org for a list of on-demand sessions.
Please join us for a scientific program covering the latest advancements in infections and immunodeficiency. Global leading experts will discuss groundbreaking research, diagnostic tools, and emerging therapies for the care of immunocompromised patients. @ChemalyRoy
Join over 900 members across 58 countries and gain access to a wealth of resources, networking opportunities, and exclusive benefits tailored to support your professional growth. Enhance patient care by actively engaging with a community of experts. ICHS.org
One day to submit your abstract to be considered for an oral or poster presentation and awards in this state-of-the-art scientific program that includes the most updated information about all aspects of infections and immunodeficiency. lnkd.in/eW6k9TN8
Happy New Year from ICHS!
One week to submit your abstract to be considered for an oral or poster presentation in this state-of-the-art scientific program that includes the most updated information about all aspects of infections and immunodeficiency. lnkd.in/eW6k9TN8
A Note of Thanks and Holiday Wishes from ICHS.
Abstract Submission Deadline Extended! For more information on the ICHS Call for Abstracts visit: ichs.wildapricot.org/page-1863402
Tomorrow is the deadline to submit your abstract! For more information on the ICHS Call for Abstracts visit: ichs.wildapricot.org/page-1863402
5 Days to submit your abstract! For more information on the ICHS Call for Abstracts visit: ichs.wildapricot.org/page-1863402
Keynote Speaker Spotlight: Advancing the Frontiers of Cellular Immunotherapy.
Don't miss this opening session with Dr. Rezvani whose groundbreaking work in CAR NK cell therapies is redefining what’s possible in cancer treatment. Registration and more information at ichs.org. @chemalyroy
One week to submit! Deadline to submit your abstract is next Monday, December 15, 2025. For more information on the Call for Abstracts visit: ichs.wildapricot.org/page-1863402
Please take advantage of these online, dynamic sessions for pivotal moments in education, advancing research, diagnostics, and therapeutics for immunocompromised populations. Visit ichs.org for a list of on-demand sessions.
Please join us to explore and support the latest challenges and advancements for the care of immunocompromised patients. Secure your opportunity choice today at ICHS.org.
Two weeks to submit your abstract! Renowned experts of the ICHS Program Committee have prepared for a state-of-the-art scientific program. Submit your abstract by Monday, December 15th to be considered for an oral or poster presentation: ichs.wildapricot.org/page-1863402
Two weeks to submit your abstract! Renowned experts of the ICHS Program Committee have prepared for a state-of-the-art scientific program. Submit your abstract by Monday December 1st to be considered for an oral or poster presentation: ichs.wildapricot.org/page-1863402
New On Demand Education! Unlock key insights on HSV Infections in this dynamic ICHS session! Register for the recording at: ichs.org
@AiCuris Anti-infective Cures AG @chemalyroy
Submit your abstract by Monday, December 15, 2025.
Abstracts from Early Career Level Scientists are highly encouraged and are eligible for the prestigious top abstracts awards to be presented during the Symposium program.
ichs.wildapricot.org/page-1863402
Call for Abstracts are Open!
Abstracts from Early Career Level Scientists are highly encouraged and are eligible for the prestigious top abstracts awards to be presented during the Symposium program.
Submit your abstract by Monday, December 15, 2025.
Please participate in a brief survey, your insights are invaluable in helping to understand current practices, identify areas of variation, and inform future guidelines.
redcap.petermac.org.au/surveys/?s=P...